GSK2798745
Showing 1 - 6 of 6
Macular Edema Trial in Australia, New Zealand, United States (GSK2798745)
Completed
- Macular Edema
- GSK2798745
-
Sacramento, California
- +10 more
Aug 24, 2022
Healthy Volunteers Trial in Hannover (GSK2798745, Placebo, Lipoplysaccharide from Escherichia Coli)
Terminated
- Healthy Volunteers
- GSK2798745
- +3 more
-
Hannover, Niedersachsen, GermanyGSK Investigational Site
Feb 26, 2021
Cough Trial in United Kingdom (GSK2798745, Placebo)
Terminated
- Cough
- GSK2798745
- Placebo
-
Manchester, Lancashire, United Kingdom
- +7 more
Sep 6, 2019
Oedema, Pulmonary Trial in Cambridge, London (GSK2798745 solution, GSK2798745 suspension, GSK2798745 capsule)
Completed
- Oedema, Pulmonary
- GSK2798745 solution
- +5 more
-
Cambridge, United Kingdom
- +1 more
Sep 25, 2018
CHF Trial in Overland Park (GSK2798745 Micronized API without SLS and hypermellose (Tablet A), GSK2798745 Micronized API with
Completed
- Heart Failure, Congestive
- GSK2798745 Micronized API without SLS and hypermellose (Tablet A)
- +2 more
-
Overland Park, KansasGSK Investigational Site
Jan 24, 2017